American Tech Today
SEE OTHER BRANDS

Hottest science and technology news from the United States

American Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.

Press releases published on May 8, 2025

The IEC Group names the Top 25 Global EOR Providers

The IEC Group names the Top 25 Global EOR Providers

The Employer of Record (EOR) market is set to expand from $6.9 billion in 2025 to $12 billion by 2030 BASINGSTOKE, UNITED KINGDOM, May 8, 2025 /⁨EINPresswire.com⁩/ -- As businesses navigate global expansion, the demand for Employer of Record (EOR) …

Session to discuss the future of artificial intelligence and religious liberty

Session to discuss the future of artificial intelligence and religious liberty

Leading figures from the two colliding worlds of AI and religious liberty discuss the rapid development of AI and its impacts on religious liberty today. WASHINGTON, DC, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Leading figures from the two …

ArcBlock Launches ArcSphere: The World's First AI-Native Browser, Available Now

ArcBlock Launches ArcSphere: The World's First AI-Native Browser, Available Now

ArcSphere delivers a private, intelligent web experience featuring innovative Spatial Tabs for enhanced organization. SEATTLE, WA, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- ArcBlock, a pioneer in decentralized identity and AI, today launched …

UbiVac CEO Participates in Cancer Vaccine Panel at SynBioBeta & Wilson Sonsini Investment Forum

UbiVac CEO Participates in Cancer Vaccine Panel at SynBioBeta & Wilson Sonsini Investment Forum

AI will accelerate discovery, but the breakthrough is off‑the‑shelf vaccines targeting shared Dark‑Genome drivers—paired with nextgen immunotherapy combinations PALO ALTO AND SAN JOSE, CA, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- At SynBioBeta, …

Actual SEO Media, Inc. Analyzes How Google’s AI Overviews Are Reshaping Search Behavior

Actual SEO Media, Inc. Analyzes How Google’s AI Overviews Are Reshaping Search Behavior

Google’s AI Overviews are changing how users search and click. Actual SEO Media, Inc. reports on the early impacts of this new search experience. HOUSTON, TX, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Google’s AI Overviews, a feature designed to …

Entrée Resources Announces First Quarter 2025 Results

Entrée Resources Announces First Quarter 2025 Results

VANCOUVER, British Columbia, May 08, 2025 (GLOBE NEWSWIRE) -- Entrée Resources Ltd. (TSX:ETG; OTCQB:ERLFF – the “Company” or “Entrée”) has today filed its interim financial results for the first quarter ended March 31, 2025. All numbers are in U.S. dollars …

ProHance Recognized as a Representative Vendor in Gartner® Market Guide for Task Mining Tools

ProHance Recognized as a Representative Vendor in Gartner® Market Guide for Task Mining Tools

ProHance recognized as a Representative Vendor by Gartner® for enabling real-time task insights, smarter decisions, and enterprise-wide productivity gains. BENGALURU, KARNATAKA, INDIA, May 8, 2025 /⁨EINPresswire.com⁩/ -- ProHance, a leading workforce …

Less than Two Weeks to Go: Life ILS Conference 2025

Less than Two Weeks to Go: Life ILS Conference 2025

Join us on 20 May 2025 for the Life ILS Conference at EY London or online—key insights into life risk and longevity markets. LONDON, LONDON, UNITED KINGDOM, May 8, 2025 /⁨EINPresswire.com⁩/ -- With less than two weeks to go until the Life ILS Conference …

Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights

Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights

- Sharpened product candidate focus on its next-generation ADC portfolio, following strategic review and pipeline reprioritization - - Promising preclinical results with STRO-004 and dual-payload ADC, as well as STRO-006 programs presented at AACR 2025 and …

Theriva Biologics Announces Closing of $7.5 Million Public Offering

Theriva Biologics Announces Closing of $7.5 Million Public Offering

ROCKVILLE, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, …

Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights

Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights

On track for first patient dosing of SER-252 in Phase 1b clinical trial in advanced Parkinson’s disease in Q4 2025 Strengthened balance sheet with recent financing Advancing innovative POZ Platform across multiple therapeutic modalities Two new seasoned …

Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025

Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025

RESEARCH TRIANGLE PARK, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2025 financial results …

Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

Data cutoff date for Phase 2b NAVIGATE trial efficacy reached on April 30, 2025; top-line data readout expected in late June 2025 Nature Microbiology publication highlights preclinical data and the potential of CD388 as a potent, universal antiviral for …

PacBio Announces First Quarter 2025 Financial Results

PacBio Announces First Quarter 2025 Financial Results

MENLO PARK, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2025. First quarter results:   Q1 2025 Q1 2024 Revenue $37.2 million $38.8 million Instrument revenue $11.0 million …

Rackspace Technology Reports First Quarter 2025 Results

Rackspace Technology Reports First Quarter 2025 Results

Revenue of $665 million in the First Quarter, down 4% Year-over-Year Private Cloud Revenue was $250 million, down 7% Year-over-Year Public Cloud Revenue was $416 million, down 2% Year-over-Year First Quarter 2025 Cash Flow From Operating Activities was $13 …

Oculis Reports Q1 2025 Financial Results and Provides Company Update

Oculis Reports Q1 2025 Financial Results and Provides Company Update

The recent R…

Taysha Gene Therapies to Release First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15

Taysha Gene Therapies to Release First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15

DALLAS, May 08, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system ( …

Zymeworks Provides Corporate Update and Reports First Quarter 2025 Financial Results

Zymeworks Provides Corporate Update and Reports First Quarter 2025 Financial Results

Six posters presented at the American Association for Cancer Research (AACR) annual meeting Appointment of Dr. Sabeen Mekan as Senior Vice President, Clinical Development Reported $321.6 million in cash resources as of March 31, 2025 (compared to $324.2 …

4DMT Reports First Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones

4DMT Reports First Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones

Enrolled first patients in first 4D-150 Phase 3 clinical trial (4FRONT-1) in wet AMD, with over 50 clinical trial sites open to date Initiation of second 4D-150 Phase 3 clinical trial (4FRONT-2) expected in Q3 2025, with topline data from both 4FRONT-1 and …

Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Regulatory Interactions and Commercial, Medical, and Corporate Preparations On-Track for Paltusotine New Drug Application with September 25, 2025 PDUFA Date   CALM-CAH Phase 3 Study of Atumelnant for the Treatment of Adults with Congenital Adrenal …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service